It further suggests that Bcl-2 which is known to protect CLL cells from apoptosis, is a major target for Antho 50 and that its degradation via Bad dephosphorylation leads to caspase 3 activation (Fig. 8). This evidence concerns the gene BAD and B-cell chronic lymphocytic leukemia.